- $477.49m
- $889.08m
- $166.13m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 28.8 | 37.4 | 71.3 | 392 | 166 |
Cost of Revenue | |||||
Gross Profit | 21.7 | 12.9 | 34.8 | 222 | 87.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 175 | 204 | 183 | 410 | 347 |
Operating Profit | -146 | -167 | -111 | -17.8 | -181 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -152 | -211 | -115 | -49.8 | -166 |
Provision for Income Taxes | |||||
Net Income After Taxes | -152 | -211 | -115 | -49.8 | -166 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -152 | -211 | -115 | -49.8 | -166 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -152 | -211 | -115 | -49.8 | -166 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.694 | -0.461 | -0.285 | -0.095 | -0.237 |